| A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19 E Yekedüz, G Utkan, Y Ürün European Journal of Cancer 141, 92-104, 2020 | 126 | 2020 |
| Evaluation of cancer risk in patients with periodontal diseases DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ... Turkish journal of medical sciences 49 (3), 826-831, 2019 | 59 | 2019 |
| Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab E Yekedüz, B Dursun, GÇ Aydın, SC Yazgan, HH Öztürk, A Azap, G Utkan, ... Journal of Oncology Pharmacy Practice 26 (5), 1289-1294, 2020 | 30 | 2020 |
| Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors E Yekedüz, D Trapani, W Xu, EGE de Vries, C Labaki, B Gyawali, S Gulati, ... International journal of cancer 149 (7), 1455-1462, 2021 | 19 | 2021 |
| Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors SC Yazgan, E Yekedüz, G Utkan, Y Ürün The Prostate 82 (15), 1456-1461, 2022 | 18 | 2022 |
| The association between antibiotic use and survival in renal cell carcinoma patients treated with immunotherapy: a multi-center study DC Guven, R Acar, E Yekeduz, I Bilgetekin, NK Baytemur, C Erol, ... Current Problems in Cancer 45 (6), 100760, 2021 | 16 | 2021 |
| The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and … E Yekedüz, D Tural, İ Ertürk, S Karakaya, C Erol, Ö Ercelep, Ç Arslan, ... Journal of Cancer Research and Clinical Oncology 148 (12), 3537-3546, 2022 | 12 | 2022 |
| A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? E Yekedüz, AM Karcıoğlu, G Utkan, Y Ürün Future Oncology 16 (25), 1879-1881, 2020 | 12 | 2020 |
| Systemic immune-inflammation Index as a prognostic marker of late recurrence in operable gastric cancer: a dual-center study E Yekedüz, İ Dogan, DM Kaya, İ Özgür, G Utkan, S Vatansever, S Demirci, ... Journal of Gastrointestinal Cancer, 1-10, 2022 | 11 | 2022 |
| The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors KB Yücel, E Yekedüz, S Karakaya, D Tural, İ Ertürk, C Erol, Ö Ercelep, ... Scientific Reports 12 (1), 1-9, 2022 | 9 | 2022 |
| Comparison of Clinical and Pathological Factors Affecting Early and Late Recurrences in Patients with Operable Breast Cancer E Yekedüz, Ö Dizdar, N Kertmen, S Aksoy Journal of Clinical Medicine 11 (9), 2332, 2022 | 7 | 2022 |
| A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma E Yekedüz, H Arzu Yaşar, G Utkan, Y Ürün Journal of Oncology Pharmacy Practice 26 (4), 972-981, 2020 | 7 | 2020 |
| Risk altındaki erişkinlerin Pnömokok ve İnfluenza aşılanma oranları ve aşıya karşı tutumları L ÖZIŞIK, E YEKEDÜZ, MD TANRIÖVER, Ö HELVACI, NÇ BAŞARAN, ... Flora 21 (1), 15-20, 2016 | 6 | 2016 |
| Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis Z Bakouny, E Yekedüz, DA Braun, JE Berchuck, L Hirsch, G Utkan, Y Lee, ... Critical reviews in oncology/hematology 166, 103463, 2021 | 4 | 2021 |
| Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study E Yekedüz, İ Doğan, SD Birgi, M Keskin, Ş Karaman, G Utkan, ... Euroasian Journal of Hepato-Gastroenterology 11 (2), 51, 2021 | 4 | 2021 |
| ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis E Yekedüz, EB Köksoy, H Akbulut, Y Ürün, G Utkan Future Oncology 17 (03), 349-357, 2021 | 4 | 2021 |
| The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study DC Guven, E Yekeduz, E Erul, SC Yazgan, TK Sahin, G Karatas, S Aksoy, ... Journal of Cancer Research and Clinical Oncology 149 (7), 3599-3606, 2023 | 3 | 2023 |
| Genomic Landscape of Actionable Mutations in Primary and Metastatic Tissues of Colon Adenocarcinoma E Yekedüz, H Akbulut, G Utkan, Y Urun, Y Ürün Cureus Journal of Medical Science 14 (4), 2022 | 3 | 2022 |
| mRNA-based COVID-19 vaccines appear to not increase immune events in cancer patients receiving immune checkpoint inhibitors E Yekedüz, R Ayasun, EB Köksoy, G Utkan, Y Ürün, H Akbulut Future Virology 16 (9), 583-585, 2021 | 3 | 2021 |
| Nivolumab in metastatic renal cell carcinoma: results from the Turkish Oncology Group Kidney Cancer Consortium database E Yekedüz, İ Ertürk, D Tural, N Karadurmuş, S Karakaya, M Hızal, ... Future Oncology 17 (35), 4861-4869, 2021 | 3 | 2021 |
